From Biofluid Detectability to Bladder-Cancer-Specific Validation: Interpreting CTSV as a Noninvasive Biomarker. Zeng D, Li J. Int J Urol 2026;33:e70650.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeng D, Li J. From Biofluid Detectability to Bladder-Cancer-Specific Validation: Interpreting CTSV as a Noninvasive Biomarker. Int J Urol 2026;33:e70650.
PMID: 42865134